Expanded Access to NanoDoce


NanOlogy may consider offering expanded access to NanoDoce for patients who do not meet the enrollment criteria of clinical trials in progress.

Study Type

  • Study Type: Expanded Access


  • Drug: NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension

Participating in This Clinical Trial

Inclusion Criteria

- Exclusion Criteria:


Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • NanOlogy, LLC
  • Collaborator
    • US Biotest, Inc.
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Gere diZerega, MD, 805-595-1300, gere.dizerega@usbiotest.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.